# Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study

> **NCT07673640** · — · RECRUITING · sponsor: **ShanShan Li** · enrollment: 300 (estimated)

## Conditions studied

- Non-Segmental Vitiligo (NSV)

## Interventions

- **DRUG:** 1.5% Ruxolitinib Phosphate Cream (Opzelura)
- **DRUG:** Corticosteroid Therapy

## Key facts

- **NCT ID:** NCT07673640
- **Lead sponsor:** ShanShan Li
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-02
- **Primary completion:** 2026-12
- **Final completion:** 2028-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07673640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07673640, "Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07673640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*